Sri Sai Therapeutics (India) Private Limited
Manufactures and sells medical, precision, and optical instruments and equipment.
2020 | Bangaluru, Karnataka (India) | Active
Sri Sai Therapeutics (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 4 Year, 6 Months
About Sri Sai Therapeutics (India)
Sri Sai Therapeutics (India) Private Limited (SSTIPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 August 2020 (Four years and six months 23 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Ravindranath Sholapurmath and Girish Koppar serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33309KA2020PTC137029
- Company No.
137029
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Aug 2020
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Healthcare
Consumer Goods
Who are the key members and board of directors at Sri Sai Therapeutics (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girish Koppar  | Director | 08-Aug-2020 | Current |
| Ravindranath Sholapurmath | Director | 08-Aug-2020 | Current |
Financial Performance of Sri Sai Therapeutics (India).
Enhance accessibility to Sri Sai Therapeutics (India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sri Sai Therapeutics (India)?
Unlock access to Sri Sai Therapeutics (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sri Sai Therapeutics (India)?
Sri Sai Therapeutics (India) has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Sai Therapeutics (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Sai Therapeutics (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Sri Sai Therapeutics (India)
Recent activity within the organization
- Director Appointment
Ravindranath Gurumurtayya Sholapurmath was appointed as a Director was appointed as a Director on 08 Aug 2020 & has been associated with this company since 4 years 6 months .
08 Aug 2020
- Director Appointment
Girish Hanamant Koppar was appointed as a Director was appointed as a Director on 08 Aug 2020 & has been associated with this company since 4 years 6 months .
08 Aug 2020
- Company Incorporation
Sri Sai Therapeutics (India) Private Limited was registered on 08 Aug 2020 with Roc Bangalore & aged 4 years 6 months as per MCA records.
08 Aug 2020
Frequently asked questions
What is the Incorporation or founding date of Sri Sai Therapeutics (India) Private Limited?
Sri Sai Therapeutics (India) Private Limited was incorporated on 08 Aug 2020.
What is authorized share capital and paid-up capital of Sri Sai Therapeutics (India) Private Limited?
The authorized share capital of Sri Sai Therapeutics (India) Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.20 M.
Who are the current board members & directors of Sri Sai Therapeutics (India) Private Limited?
Currently 2 directors are associated with Sri Sai Therapeutics (India) Private Limited.
- Ravindranath Gurumurtayya Sholapurmath
- Girish Hanamant Koppar
What is the registered address of Sri Sai Therapeutics (India) Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Sri Sai Therapeutics (India) Private Limited is 413 2Nd Floor 6Th Block Dr Rajkumar Road Rajajinagar , India, Bengaluru, Karnataka, 560010.
What is the corporate identification number (CIN) and company number of Sri Sai Therapeutics (India) Private Limited?
The corporate identification number (CIN) of Sri Sai Therapeutics (India) Private Limited is U33309KA2020PTC137029 and the company number is 137029 as per Ministry of Corporate Affairs (MCA).